Pa. High Court Nixes Teva Appeal In Reglan Preemption Fight
The Pennsylvania Supreme Court on Wednesday rejected an appeal by Teva Pharmaceuticals USA Inc. and other generic drugmakers battling a lower court's ruling that product liability claims of thousands of generic...To view the full article, register now.
Already a subscriber? Click here to view full article